Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC.
第一作者:
Chunmeng,Zhang
第一单位:
Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);阑尾肿瘤(Appendiceal Neoplasms);综合疗法(Combined Modality Therapy);女(雌)性(Female);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);男(雄)性(Male);中年人(Middle Aged);丝裂霉素(Mitomycin);腹膜肿瘤(Peritoneal Neoplasms);预后(Prognosis);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));回顾性研究(Retrospective Studies);Smad4蛋白质(Smad4 Protein);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1002/jso.26439
PMID
33667317
发布时间
2021-06-04
- 浏览0

Journal of surgical oncology
1599-1609页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文